MEMBERS

If you are a member of the network, please log in to access Network content and tools. If you do not have a username, contact your site principal investigator or site coordinator and request that they complete a membership request for you. If you have forgotten your password, you may CLICK HERE.


AS ATN

You are here

Home

Publications

Export 164 results:
[ Author(Desc)] Title Type Year
Filters: Type is not Conference Abstract  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Adkins KW, Molloy CA, Weiss SK, Reynolds AM, Goldman SE, Burnette C, et al.. Effects of a standardized pamphlet on insomnia in children with autism spectrum disorders. Pediatrics. 2012 ;130:S139-44. NLM Journal Code: oxv, 0376422
Adkins KW, Goldman SE, Fawkes DB, Surdyka K, Wang L, Song Y, et al.. A Pilot Study of Shoulder Placement for Actigraphy in Children. Behavioral Sleep Medicine [Internet]. 2012 ;10:138-147. http://dx.doi.org/10.1080/15402002.2011.596598 doi: 10.1080/15402002.2011.596598; M3: doi: 10.1080/15402002.2011.596598; 22
Aman MG, Hollway JA, Veenstra-VanderWeele J, Handen BL, Sanders KB, Chan J, et al.. Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use. J Child Adolesc Psychopharmacol. 2018 ;28(4):266-273.
Ameis SH, Corbettdick P, Cole L, Correll CU. Decision Making and Antipsychotic Medication Treatment for Youth With Autism Spectrum Disorders: Applying Guidelines in the Real World. The Journal of Clinical Psychiatry. 2013 ;74:1022-1024.
Anagnostou E, Aman MG, Handen BL, Sanders KB, Shui AM, Hollway JA, et al.. Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: a randomized clinical trial. JAMA Psychiatry. 2016 ;73:928–937.
Anixt J, Murray D, Coury D, Kuhlthau K, Eskra D, Seide J, et al.. Improving Behavior Challenges and Quality of Life in the Autism Learning Health Network. Pediatrics Supplement. 2020 ;.
Arnold G, Luna RA, Williams K, Chan J, Parker RA, Wu Q, et al.. Probiotics for gastrointestinal symptoms and quality of life in autism: a placebo-controlled pilot trial. J. of Child& Adolescent Psychopharmacology. 2019 ;.
Austin J, Manning-Courtney P, Johnson ML, Weber R, Johnson H, Murray DS, et al.. Improving access to care at autism treatment centers: a system analysis approach. Pediatrics. 2016 ;137:S149–S157.
B
Bellando J, Fussell JJ, Lopez M. Autism Speaks Toolkits: Resources for Busy Physicians. Clinical Pediatrics. 2015 ;.
Bellesheim KR, Cole L, Coury DL, Yin L, Levy SE, Guinnee MA, et al.. Family-Driven Goals to Improve Care for Children With Autism Spectrum Disorder. Pediatrics. 2018 ;142(3).
Broder-Fingert S, Shui AM, Ferrone C, Iannuzzi D, Cheng ER, Giauque A, et al.. A pilot study of autism-specific care plans during hospital admission. Pediatrics. 2016 ;137:S196–S204.
Broder-Fingert S, Shui AM, Pulcini CD, Kurowski D, Perrin JM. Racial and ethnic differences in subspecialty service use by children with autism. Pediatrics. 2013 ;132(1):94-100.
C
Capal JK, Macklin EA, Lu F, Barnes G. Factors Associated with Seizure Onset in Children with Autism Spectrum Disorde. Pediatrics Supplement. 2020 ;.
Chatham CH, Taylor K, Charman T, C D'ardhuy L, Eule E, Fedele A, et al.. Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II. Autism Research. 2017 ;.
Coury DL, Anagnostou E, Manning-Courtney P, Reynolds AM, Cole L, McCoy R, et al.. Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics. 2012 ;130:S69-76. NLM Journal Code: oxv, 0376422
Coury DL, Swedo S, Thurm A, Miller D, Veenstra-VanderWeele J, Carbone P, et al.. Treating the Whole Person With Autism: The Proceedings of the Autism Speaks National Autism Conference. Current Problems in Pediatric and Adolescent Health Care. 2014 ;44:26-47.
Coury DL. Babies, Bathwater, and Screening for Autism Spectrum Disorder: Comments on the USPSTF Recommendations for Autism Spectrum Disorder Screening. Journal of Developmental & Behavioral Pediatrics . 2015 ;36(9):661-3.
Coury DL. Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders. Evidence-Based Mental Health. 2011 ;14:105. JID: 100883413; CON: Pediatrics. 2011 May;127(5):e1312-21. PMID: 21464191; 2011/09/30 [aheadofprint]; ppublish
Coury DL. Very little high-quality evidence to support most medications for children with autism spectrum disorders. The Journal of Pediatrics. 2011 ;159:872-873.
Coury DL. DSM-5 and autism spectrum disorders: implications for families and clinicians. Journal of Developmental and Behavioral Pediatrics. 2013 ;34:494-496. JID: 8006933; ppublish
Coury D, Murray D, Fedele A, Hess T, Kelly A, Kuhlthau K. The Autism Treatment Network: Bringing best practices to all children with autism. Pediatrics Supplement. 2020 ;.
Coury DL, Jones NE, Klatka K, Winklosky B, Perrin JM. Healthcare for children with autism: the Autism Treatment Network. Current Opinion in Pediatrics. 2009 ;21:828-832. GR: UA3 MC 11054/PHS HHS/United States; JID: 9000850; RF: 24; ppublish
Coury DL, Ashwood P, Fasano A, Fuchs G, Geraghty M, Kaul A, et al.. Gastrointestinal conditions in children with autism spectrum disorder: developing a research agenda. Pediatrics. 2012 ;130:S160-8. NLM Journal Code: oxv, 0376422
Coury DL. Medical treatment of autism spectrum disorders. Current Opinion in Neurology. 2010 ;23:131-136. LR: 20130118; GR: UA3 MC 11054/PHS HHS/United States; JID: 9319162; RF: 53; ppublish
Crossman MK, Lindly OJ, Chan J, Eaves M, Kuhlthau KA, Parker RA, et al.. Families’ Experiences with Family Navigation Services in the Autism Treatment Network. Pediatrics Supplement. 2020 ;.

Pages